Low risk of elevated IOP with lampalizumab for geographic atrophy over 1 year
July 2nd 2024Repeated 0.1-ml intravireal injections of lampalizumab, antigen-binding fragment of a humanized monoclonal antibody that inhibits complement factor D, seem to be associated with a low risk of elevated IOP
Read More
Study: Low-dose aspirin doesn't affect the incidence or progression of AMD
May 28th 2024Investigators undertook a secondary analysis of the effects of long-term, low-dose aspirin in over 3,000 older adults who satisfied the inclusion criteria in the Aspirin in Reducing Events in the Elderly–AMD (ASPREE-AMD) study.
Read More